Notice of Annual and Special Meeting Of Shareholders Aug 19, 2022 Notice of Annual and Special Meeting Of Shareholders Notice of Meeting and Management Information Circular for the Annual And Special Meeting of Shareholders to be held on September 19, 2022 Form of Proxy Voting Instruction Form Request for Financial Statements Email Sign Up Success! First Name Last Name Email Subscribe Recent News Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases Mar 11, 2026read more Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study Dec 15, 2025read more Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study Nov 21, 2025read more Revive Therapeutics Announces Closing of Second Tranche of Private Placement Sep 19, 2025read more
Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases Mar 11, 2026read more
